CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 157 enrolled
Drug / intervention
Aequalis Pyrocarbon Humeral Headdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02525783
NCT02525783N/ACompleted
CompareCT.gov

Aequalis Pyrocarbon Humeral Head IDE Study

Stryker Trauma and Extremities·interventional·Posted Aug 17, 2015·Updated Jan 19, 2023

In Brief

A clinical study evaluating Aequalis Pyrocarbon Humeral Head for Osteoarthritis and 2 related conditions. Completed, enrolled 157 participants across 1 site.

Detailed Summary

The purpose of this study is to demonstrate safety and effectiveness of the Aequalis Pyrocarbon Humeral Head in hemiarthroplasty at 24 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Avascular Necrosis, Traumatic Arthritis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 17, 2015
Enrollment StartDec 1, 2015
Primary CompletionJul 19, 2019
Study CompletionOct 7, 2022
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 10.9 years ago

Interventions

Aequalis Pyrocarbon Humeral Headdevice

Hemi Shoulder Arthroplasty